Literature DB >> 30049739

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions.

Eva Polverino1,2,3, Katerina Dimakou4, John Hurst5, Miguel-Angel Martinez-Garcia6, Marc Miravitlles1,2,3, Pierluigi Paggiaro7, Michal Shteinberg8,9, Stefano Aliberti10,11, James D Chalmers12.   

Abstract

Bronchiectasis is a clinical and radiological diagnosis associated with cough, sputum production and recurrent respiratory infections. The clinical presentation inevitably overlaps with other respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). In addition, 4-72% of patients with severe COPD are found to have radiological bronchiectasis on computed tomography, with similar frequencies (20-30%) now being reported in cohorts with severe or uncontrolled asthma. Co-diagnosis of bronchiectasis with another airway disease is associated with increased lung inflammation, frequent exacerbations, worse lung function and higher mortality. In addition, many patients with all three disorders have chronic rhinosinusitis and upper airway disease, resulting in a complex "mixed airway" phenotype.The management of asthma, bronchiectasis, COPD and upper airway diseases has traditionally been outlined in separate guidelines for each individual disorder. Recognition that the majority of patients have one or more overlapping pathologies requires that we re-evaluate how we treat airway disease. The concept of treatable traits promotes a holistic, pathophysiology-based approach to treatment rather than a syndromic approach and may be more appropriate for patients with overlapping features.Here, we review the current clinical definition, diagnosis, management and future directions for the overlap between bronchiectasis and other airway diseases.
Copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 30049739     DOI: 10.1183/13993003.00328-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  39 in total

1.  Journal Club - Bronchiectasis/COPD Overlap: Syndrome Versus Treatable Trait?

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04

2.  Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?

Authors:  Simone K Visser; Peter T P Bye; Greg J Fox; Lucy D Burr; Anne B Chang; Chien-Li Holmes-Liew; Paul King; Peter G Middleton; Graeme P Maguire; Daniel Smith; Rachel M Thomson; Enna Stroil-Salama; Warwick J Britton; Lucy C Morgan
Journal:  Lung       Date:  2019-11-05       Impact factor: 2.584

3.  Journal Club-- COPD Exacerbations and Gastroesophageal Reflux Disease: Why Proton Pump Inhibitor Therapy is Not Enough.

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

4.  Validation of the COPD Assessment Test (CAT) as an Outcome Measure in Bronchiectasis.

Authors:  Simon Finch; Irena F Laska; Hani Abo-Leyah; Thomas C Fardon; James D Chalmers
Journal:  Chest       Date:  2019-11-12       Impact factor: 9.410

5.  Mutagenic damage among bronchiectasis patients attending in the pulmonology sector of a hospital in southern Brazil.

Authors:  Daniel Wenceslau Votto Olmedo; Katheryne Benini Martins; Milene Machado Paz; Caroline Lopes Feijo Fernandes; Flavio Manoel Rodrigues da Silva Júnior; Daniela Fernandes Ramos
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

Review 6.  Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review.

Authors:  Miguel Ángel Martínez-García; Mario Cazzola; Grace Oscullo; Alberto García-Ortega; Maria Gabriella Matera; Paola Rogliani
Journal:  Drugs       Date:  2022-10-20       Impact factor: 11.431

7.  Strong and consistent associations of precedent chronic rhinosinusitis with risk of non-cystic fibrosis bronchiectasis.

Authors:  Brian S Schwartz; Saba A Al-Sayouri; Jonathan S Pollak; Annemarie G Hirsch; Robert Kern; Bruce Tan; Atsushi Kato; Robert P Schleimer; Anju T Peters
Journal:  J Allergy Clin Immunol       Date:  2022-03-18       Impact factor: 14.290

8.  Prevalence and characterization of chronic rhinosinusitis in patients with non-cystic fibrosis bronchiectasis at a tertiary care center in the United States.

Authors:  Shaan N Somani; Jason H Kwah; Chen Yeh; David B Conley; Leslie C Grammer; Robert C Kern; Michelle Prickett; Robert P Schleimer; Stephanie S Smith; Whitney W Stevens; Bruce K Tan; Kevin C Welch; Anju T Peters
Journal:  Int Forum Allergy Rhinol       Date:  2019-10-07       Impact factor: 3.858

9.  Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition.

Authors:  Holly R Keir; Christopher J Fong; Megan L Crichton; Philip Barth; Eric Chevalier; Gill Brady; Gwen Kennedy; Johann Zimmermann; Piet L B Bruijnzeel; Alison J Dicker; James D Chalmers
Journal:  ERJ Open Res       Date:  2019-03-25

10.  Chronic Bronchitis in COPD Patients Creates Worse Symptom Burden Regardless of the Presence of Bronchiectasis in the COPDGene Cohort.

Authors:  Oksana Bohn; Min Xi; Natalie K Woodruff; Gary L Hansen; Charlene E McEvoy
Journal:  Chronic Obstr Pulm Dis       Date:  2021-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.